ERBB2 and breast cancer: The advent of tools to identify cell type and, subsequently, to create molecular tumor profiles that could probe the pathophysiology of cancer led to the discovery of the BRCA-2 and HER-2 gene mutations, which in turn showed that “breast cancer” was in fact a heterogenous mosaic of tumors (41).